GLP-1 Injection Weight Loss Peptide Tirzepatide Semaglutide Liraglutide 5mg 10mg CAS 238

Retatrutide is an investigational single molecule that activates the body's receptors for three hormones - glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1), and is being studied for the treatment of obesity.

It employs a triple-agonist (triple-G) mechanism of action. In addition to being a GLP-1RA, it also targets gastric inhibitory polypeptide receptor (GIPR), and glucagon receptor (GCGR). This has consequently shown increased efficacy benefits in clinical trials, superior to those seen with W, which facilitates around -15% body weight loss.

Semaglutide is a polypeptide that contains a linear sequence of 31 amino acids joined together by peptide linkages. It is an agonist of glucagon-like peptide 1 receptors (GLP1 AR) and used for the treatment of type 2 diabetes. 

It has a role as a hypoglycemic agent, a glucagon-like peptide-1 receptor agonist, an anti-obesity agent, a neuroprotective agent and an appetite depressant. It is a polypeptide and a lipopeptide.

Semax is a kind of nootropic that was extensively developed in Russia in the 1980s-90s. It is used as a treatment for cognitive degeneration and brain damage, especially for victims of stroke.

A synthetic form of the adrenocorticotropic hormone, it is delivered into the body via a Semax nasal spray. It works like regular human hormones in counteracting stress brought about by environmental factors.

A hormone secreted by the pituitary gland, that stimulates the release of cortisol from the adrenal gland, which in turn regulates glucose metabolism and maintains blood pressure.